Usui Noriko | Jikei University Hospital
スポンサーリンク
概要
関連著者
-
Usubuchi Noriko
国立がんセンター中央病院
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
Usubuchi Noriko
Hematology And Oncology Division National Cancer Center Hospital East
-
Uoshima Nobuhiko
京都府立医科大学 血液・腫瘍内科学
-
Uike N
National Kyusyu Cancer Center
-
USUI Noriko
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center
-
Uoshima Nobuhiko
Matsushita Memorial Hospital Moriguchi Jpn
-
DOBASHI Nobuaki
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
Yamaguchi Yuko
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
著作論文
- Elevated serum levels of human matrix metalloproteinase-9 (MMP-9) during the induction of peripheral blood stem cell mobilization by granulocyte colony-stimulating factor (G-CSF)
- Intensifying Daunorubicin in Induction for Patients with Core Binding Factor Leukemia
- Intensified Daunorubicin in Induction Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Postremission Therapy (Double-7 Protocol) for Adult Acute Myeloid Leukemia
- Severe Aplastic Anemia Associated With Chronic Natural Killer Cell Lymphocytosis
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Early cytomegalovirus (CMV) gastrointestinal disease that developed 19 days after bone marrow transplantation, with a high-level of CMV antigenemia, of up to 1120 cells/slide
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia